General
Preferred name
LINEZOLID
Synonyms
PNU-100766 ()
Linezolid (PNU-100766) ()
Zyvoxid, Zyvoxam,PNU-100766 ()
U-100,766 ()
Linezolide ()
Zyvox ()
U-100766 ()
Linezolid-d3 ()
P&D ID
PD001291
CAS
165800-03-3
1127120-38-0
Tags
available
drug
Approved by
FDA
First approval
2000
Drug indication
Antibacterial
Bacterial infection
Drug Status
approved
investigational
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Linezolid is a synthetic oxazolidinone class antibacterial with activity against Gram-positive pathogens . It also has activity as a MAO (monoamine oxidase) inhibitor.
(GtoPdb)
DESCRIPTION
Antibiotic; inhibits 50S ribosomal subunit formation and elongation at transpeptidation
(Tocris Bioactive Compound Library)
DESCRIPTION
Antibiotic; inhibits protein synthesis in gram-positive bacteria
(Tocriscreen Plus)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
1
Organisms
6
Compound Sets
25
AdooQ Bioactive Compound Library
Axon Medchem Screening Library
ChEMBL Approved Drugs
ChEMBL Drugs
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Enamine BioReference Compounds
Guide to Pharmacology
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
Tocris Bioactive Compound Library
Tocriscreen Plus
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
52
Molecular Weight
337.14
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
1
Rotatable Bonds
4
Ring Count
3
Aromatic Ring Count
1
cLogP
1.12
TPSA
71.11
Fraction CSP3
0.5
Chiral centers
1.0
Largest ring
6.0
QED
0.89
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target Type
Cell Biology
Pathway
Metabolism
Neuroscience
Anti-infection
Target
AOA
AOB
MAOA, MAOB
antibiotic
Bacterial
Primary Target
DNA, RNA and Protein Synthesis
MOA
Inhibitor
bacterial 50S ribosomal subunit inhibitor
Indication
pneumonia, skin infections
Therapeutic Class
Antibiotics
Source data